PFBT
DNTH icon

Parkside Financial Bank & Trust’s Dianthus Therapeutics DNTH Stock Holding History

Parkside Financial Bank & Trust’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.1K Buy
1,050
+100
+11% +$5.79K 0.01% 736
2025
Q4 		$39.1K Hold
950
– – ﹤0.01% 1055
2025
Q3 		$37.4K Buy
950
+540
+132% +$13.8K ﹤0.01% 1034
2025
Q2 		$7.64K Buy
410
+25
+6% +$469 ﹤0.01% 1573
2025
Q1 		$6.98K Hold
385
– – ﹤0.01% 1534
2024
Q4 		$8.39K Hold
385
– – ﹤0.01% 1326
2024
Q3 		$10.5K Buy
+385
New +$10.7K ﹤0.01% 1230

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parkside Financial Bank & Trust's DNTH Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Dianthus Therapeutics (DNTH) stake by 11% in Q1 2026, buying an estimated $5.79K and bringing the position to 1,050 shares worth $88.1K. The position accounts for 0.01% of the portfolio, ranked #736.

Parkside Financial Bank & Trust first reported a position in DNTH in Q3 2024 and has held it in 7 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Parkside Financial Bank & Trust held 1,050 shares of Dianthus Therapeutics worth $88.1K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 100 Dianthus Therapeutics shares in Q1 2026, an estimated $5.79K.
  • Dianthus Therapeutics made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #736 holding.
  • Parkside Financial Bank & Trust first reported a position in Dianthus Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.